
U.S. Baby Infant Formula Market By Product Type (Infant Milk, Follow-On-Milk, Specialty Milk, and Growing Up Milk), Ingredients (Carbohydrate, Fat, Protein, Minerals, Vitamins, and Others) and Distribution Channel (Hypermarket, Supermarket, Pharmacy/Medic
Description
U.S. Baby Infant Formula Market By Product Type (Infant Milk, Follow-On-Milk, Specialty Milk, and Growing Up Milk), Ingredients (Carbohydrate, Fat, Protein, Minerals, Vitamins, and Others) and Distribution Channel (Hypermarket, Supermarket, Pharmacy/Medical Stores, Specialty Stores, Hard Discount Stores, and Others): Opportunity Analysis And Industry Forecast, 2021-2030
The U.S. baby infant formula market was valued at $3,889.0 million in 2020, and is projected to reach $6,784.7 million by 2030, registering a CAGR of 8.6% from 2021 to 2030.
Infant formula serves as an ideal alternative suitable for infant consumption, which mimics the nutritional composition of breast milk as closely as possible. Although physicians recommend breast milk for optimal infant nutrition, it may not always be possible, suitable, or solely adequate. Enspire infant formula and toddler milk and Similac infant formula and toddler milk are infant formulas available for healthy, full-term infants who are not breastfed or partially breastfed.
The rise in the participation of women in the labor force in the U.S. acts as a key driving force of the U.S. baby infant formula market. For instance, according to the U.S. Bureau of Statistics, the working women population increased from 57.1% in 2018 to 57.5% in 2020. Infant formula acts as an appealing alternative to working mothers for their babies as per the need and convenience. Rapid urbanization and the growth of the middle-class population have led to changes in lifestyle.
The middle-class population is more affluent and can afford to spend more on their children, thus driving market growth. In addition, consumer perception of the high nutritional content in the infant formula supplements the market growth. Furthermore, an increase in health consciousness among consumers boosts the demand for infant formula having a high content of protein, minerals, and vitamins. However, concerns related to food safety and the decline in the birth rate are anticipated to hamper the market growth. On the contrary, a shift in preference for organic infant formulas is expected to offer new avenues for manufacturers.
The U.S. baby infant formula market is segmented on the basis of product type, ingredient, distribution channel, and source. Depending on product type, the market is segregated into infant milk, follow-on milk, specialty baby milk, and growing-up milk. On the basis of ingredient, it is fragmented into carbohydrates, fat, protein, minerals, vitamins, and others. By distribution channel, it is categorized into hypermarkets, supermarkets, pharmacy/medical stores, specialty stores, hard discounter stores, and others. By source, it is classified into regular, organic, milk with HMO, goat milk, plant-based formula, and others.
The major players analyzed for the U.S. Baby Infant Formula Market are Abott Laboratories, Alra Foods Amba, Aussie Bub, Bobbie, Campbell Soups Company, Dana Dairy Group Ltd., Danone SA, D-Signstore, Else Nutrition Holdings Inc., Hipp GmbH & Co. Vertrieb KG, Holle Baby Food AG, Kabrita USA, Nature’s One, LLC, Nestle S.A, Reckitt Benckiser Group Plc, and The Hain Celestial Group, Inc.
Key benefits for the stakeholder
By Product Type
Infant milk
Follow-on-milk
Specialty baby milk
Growing-up milk
By Ingredient
Carbohydrate
Fat
Protein
Minerals
Vitamins
others
By Distribution Channel
Hypermarkets
Supermarkets
Pharmacy/medical stores
Specialty stores
Hard discounter stores
others
By Source
Regular
Organic
Milk with HMO
Goat milk
Plant-based formula
Others
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
The U.S. baby infant formula market was valued at $3,889.0 million in 2020, and is projected to reach $6,784.7 million by 2030, registering a CAGR of 8.6% from 2021 to 2030.
Infant formula serves as an ideal alternative suitable for infant consumption, which mimics the nutritional composition of breast milk as closely as possible. Although physicians recommend breast milk for optimal infant nutrition, it may not always be possible, suitable, or solely adequate. Enspire infant formula and toddler milk and Similac infant formula and toddler milk are infant formulas available for healthy, full-term infants who are not breastfed or partially breastfed.
The rise in the participation of women in the labor force in the U.S. acts as a key driving force of the U.S. baby infant formula market. For instance, according to the U.S. Bureau of Statistics, the working women population increased from 57.1% in 2018 to 57.5% in 2020. Infant formula acts as an appealing alternative to working mothers for their babies as per the need and convenience. Rapid urbanization and the growth of the middle-class population have led to changes in lifestyle.
The middle-class population is more affluent and can afford to spend more on their children, thus driving market growth. In addition, consumer perception of the high nutritional content in the infant formula supplements the market growth. Furthermore, an increase in health consciousness among consumers boosts the demand for infant formula having a high content of protein, minerals, and vitamins. However, concerns related to food safety and the decline in the birth rate are anticipated to hamper the market growth. On the contrary, a shift in preference for organic infant formulas is expected to offer new avenues for manufacturers.
The U.S. baby infant formula market is segmented on the basis of product type, ingredient, distribution channel, and source. Depending on product type, the market is segregated into infant milk, follow-on milk, specialty baby milk, and growing-up milk. On the basis of ingredient, it is fragmented into carbohydrates, fat, protein, minerals, vitamins, and others. By distribution channel, it is categorized into hypermarkets, supermarkets, pharmacy/medical stores, specialty stores, hard discounter stores, and others. By source, it is classified into regular, organic, milk with HMO, goat milk, plant-based formula, and others.
The major players analyzed for the U.S. Baby Infant Formula Market are Abott Laboratories, Alra Foods Amba, Aussie Bub, Bobbie, Campbell Soups Company, Dana Dairy Group Ltd., Danone SA, D-Signstore, Else Nutrition Holdings Inc., Hipp GmbH & Co. Vertrieb KG, Holle Baby Food AG, Kabrita USA, Nature’s One, LLC, Nestle S.A, Reckitt Benckiser Group Plc, and The Hain Celestial Group, Inc.
Key benefits for the stakeholder
- The report provides an in-depth analysis of the current trends, drivers, and dynamics of the U.S. baby infant formula market to elucidate the prevailing opportunities and potential investment pockets.
- It offers qualitative trends and quantitative analysis for the period of 2020–2030 to assist stakeholders to understand the market scenario.
- In-depth analysis of the key segments demonstrates the trending types across the U.S.
- Competitive intelligence of the industry highlights the business practices followed by key players across the U.S. and the prevailing market opportunities.
- The key players are profiled along with their strategies and developments to understand the competitive outlook of the industry.
By Product Type
Infant milk
Follow-on-milk
Specialty baby milk
Growing-up milk
By Ingredient
Carbohydrate
Fat
Protein
Minerals
Vitamins
others
By Distribution Channel
Hypermarkets
Supermarkets
Pharmacy/medical stores
Specialty stores
Hard discounter stores
others
By Source
Regular
Organic
Milk with HMO
Goat milk
Plant-based formula
Others
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
Table of Contents
176 Pages
- CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key benefits for the stakeholder
- 1.3.Key market segments
- 1.4.Research methodology
- 1.4.1.Primary Research
- 1.4.2.Secondary research
- 1.4.3.Analyst tools and models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key finding of the study
- 2.2.CXO perspective
- CHAPTER 3:MARKET LANDSCAPE
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter’s five force analysis
- 3.3.1.Bargaining power of suppliers
- 3.3.2.Bargaining power of buyers
- 3.3.3.Threat of new entrants
- 3.3.4.Threat of substitutes
- 3.3.5.Intensity of competitive rivalry
- 3.4.Market dynamics
- 3.4.1.Drivers
- 3.4.1.1.Increase in number of women participation in labor force
- 3.4.1.2.High nutritional content of infant formula
- 3.4.2.Restraint
- 3.4.2.1.Concerns related to food safety
- 3.4.2.2.Government initiatives to promote breastfeeding
- 3.4.3.Opportunity
- 3.4.3.1.Shift in preference toward organic baby food & drinks
- 3.4.3.2.Developments in technology result in emergence of new products
- 3.4.3.3.Extensive research on prebiotic and probiotics in baby food
- 3.5.Value chain analysis
- 3.6.Impact of key regulation
- 3.7.U.S. Infant Formula Market: COVID-19 Impact Analysis
- CHAPTER 4:U.S. BABY INFANT FORMULA MARKET, BY PRODUCT TYPE
- 4.1.Overview
- 4.1.1.Market size and forecast
- 4.2.Infant milk
- 4.2.1.Key market trends, growth factors, and opportunities
- 4.2.2.Market size and forecast
- 4.3.Follow-on milk
- 4.3.1.Key market trends, growth factors, and opportunities
- 4.3.2.Market size and forecast
- 4.4.Specialty baby milk
- 4.4.1.Key market trends, growth factors, and opportunities
- 4.4.2.Market size and forecast
- 4.4.3.Market size and forecast
- 4.5.Growing-up milk
- 4.5.1.Key market trends, growth factors, and opportunities
- 4.5.2.Market size and forecast
- CHAPTER 5:U.S. BABY INFANT FORMULA MARKET, BY INGRIDIENT
- 5.1.Overview
- 5.1.1.Market size and forecast
- 5.2.Carbohydrate
- 5.2.1.Key market trends, growth factors, and opportunities
- 5.2.2.Market size and forecast
- 5.3.Fat
- 5.3.1.Key market trends, growth factors, and opportunities
- 5.3.2.Market size and forecast
- 5.4.Protein
- 5.4.1.Key market trends, growth factors, and opportunities
- 5.4.2.Market size and forecast
- 5.5.Minerals
- 5.5.1.Key market trends, growth factors, and opportunities
- 5.5.2.Market size and forecast
- 5.6.Vitamins
- 5.6.1.Key market trends, growth factors, and opportunities
- 5.6.2.Market size and forecast
- 5.7.Others
- 5.7.1.Key market trends, growth factors, and opportunities
- 5.7.2.Market size and forecast
- CHAPTER 6:U.S. BABY INFANT FORMULA MARKET, BY DISTRIBUTION CHANNEL
- 6.1.Overview
- 6.1.1.Market size and forecast
- 6.2.Hypermarkets
- 6.2.1.Key market trends, growth factors, and opportunities
- 6.2.2.Market size and forecast
- 6.3.Supermarkets
- 6.3.1.Key market trends, growth factors, and opportunities
- 6.3.2.Market size and forecast
- 6.4.Pharmacy/medical stores
- 6.4.1.Key market trends, growth factors, and opportunities
- 6.4.2.Market size and forecast
- 6.5.Specialty stores
- 6.5.1.Key market trends, growth factors, and opportunities
- 6.5.2.Market size and forecast
- 6.6.Hard discounter stores
- 6.6.1.Key market trends, growth factors, and opportunities
- 6.6.2.Market size and forecast
- 6.7.Others
- 6.7.1.Key market trends, growth factors, and opportunities
- 6.7.2.Market size and forecast
- CHAPTER 7:U.S. BABY INFANT FORMULA MARKET, BY SOURCE
- 7.1.Overview
- 7.1.1.Market size and forecast
- 7.2.Regular
- 7.2.1.Key market trends, growth factors, and opportunities
- 7.2.2.Market size and forecast
- 7.3.Organic
- 7.3.1.Key market trends, growth factors, and opportunities
- 7.3.2.Market size and forecast
- 7.4.Milk with HMO
- 7.4.1.Key market trends, growth factors, and opportunities
- 7.4.2.Market size and forecast
- 7.5.Goat Milk
- 7.5.1.Key market trends, growth factors, and opportunities
- 7.5.2.Market size and forecast
- 7.6.Plant-based formula
- 7.6.1.Key market trends, growth factors, and opportunities
- 7.6.2.Market size and forecast
- 7.7.Others
- 7.7.1.Key market trends, growth factors, and opportunities
- 7.7.2.Market size and forecast
- CHAPTER 8:COMPETITION LANDSCAPE
- 8.1.Top winning strategies
- 8.2.Product mapping
- 8.3.Competitive dashboard
- 8.4.Competitive heat map
- 8.5.Key developments
- 8.5.1.Acquisition
- 8.5.2.Business Expansion
- 8.5.3.Product Launch
- 8.5.4.Agreement
- CHAPTER 9:COMPANY PROFILES
- 9.1.ABBOTT LABORATORIES
- 9.1.1.Company snapshot
- 9.1.2.Operating business segments
- 9.1.3.Product portfolio
- 9.1.4.Distribution channel
- 9.1.5.R&D expenditure
- 9.1.6.Business performance
- 9.2.ARLA FOODS AMBA
- 9.2.1.Company snapshot
- 9.2.2.Operating business segments
- 9.2.3.Product portfolio
- 9.2.4.Distribution channel
- 9.2.5.Business performance
- 9.2.6.Key strategic moves and developments
- 9.3.AUSSIE BUBS, Inc
- 9.3.1.Company snapshot
- 9.3.2.Product portfolio
- 9.3.3.Distribution channel
- 9.3.4.Business performance
- 9.3.5.Key strategic moves and developments
- 9.4.BOBBIE
- 9.4.1.Company snapshot
- 9.4.2.Product portfolio
- 9.4.3.Distribution channel
- 9.4.4.Key strategic moves and developments
- 9.5.CAMPBELL SOUPS COMPANY
- 9.5.1.Company snapshot
- 9.5.2.Operating business segments
- 9.5.3.Product portfolio
- 9.5.4.Distribution channel
- 9.5.5.R&D expenditure
- 9.5.6.Business performance
- 9.6.DANA DAIRY GROUP LTD.
- 9.6.1.Company snapshot
- 9.6.2.Product portfolio
- 9.6.3.Distribution channel
- 9.6.4.Key strategic moves and developments
- 9.7.DANONE SA
- 9.7.1.Company snapshot
- 9.7.2.Operating business segments
- 9.7.3.Product portfolio
- 9.7.4.Distribution channel
- 9.7.5.Business performance
- 9.8.D-SIGNSTORE
- 9.8.1.Company snapshot
- 9.8.2.Product portfolio
- 9.8.3.Distribution channel
- 9.9.ELSE NUTRITION HOLDINGS INC.
- 9.9.1.Company snapshot
- 9.9.2.Product portfolio
- 9.9.3.Distribution channel
- 9.9.4.Key strategic moves and developments
- 9.10.HIPP GmbH & CO. VERTRIEB KG
- 9.10.1.Company snapshot
- 9.10.2.Product portfolio
- 9.10.3.Distribution channel
- 9.11.HOLLE BABY FOOD AG
- 9.11.1.Company snapshot
- 9.11.2.Product portfolio
- 9.11.3.Distribution channel
- 9.12.KABRITA USA
- 9.12.1.Company snapshot
- 9.12.2.Product portfolio
- 9.12.3.Distribution channel
- 9.13.NATURE’S ONE, LLC
- 9.13.1.Company snapshot
- 9.13.2.Product portfolio
- 9.13.3.Distribution channel
- 9.13.4.Key strategic moves and developments
- 9.14.NESTLE S.A.
- 9.14.1.Company snapshot
- 9.14.2.Operating business segments
- 9.14.3.Product portfolio
- 9.14.4.Distribution channel
- 9.14.5.Business performance
- 9.14.6.Key strategic moves and developments
- 9.15.RECKITT BENCKISER GROUP PLC
- 9.15.1.Company snapshot
- 9.15.2.Operating business segments
- 9.15.3.Product portfolio
- 9.15.4.Distribution channel
- 9.15.5.R&D Expenditure
- 9.15.6.Business performance
- 9.16.THE HAIN CELESTIAL GROUP, INC.
- 9.16.1.Company snapshot
- 9.16.2.Product portfolio
- 9.16.3.Distribution channel
- 9.16.4.R&D Expenditure
- 9.16.5.Business performance
- LIST OF TABLES
- TABLE 01.U.S. BABY INFANT FORMULA MARKET VALUE, BY PRODUCT TYPE, 2020–2030 ($MILLION)
- TABLE 02.U.S. BABY INFANT FORMULA MARKET VOLUME, BY PRODUCT TYPE, 2020–2030 (KILOTON)
- TABLE 03.U.S. BABY INFANT MILK MARKET VALUE, 2020–2030 ($MILLION)
- TABLE 04.U.S. BABY INFANT MILK MARKET VOLUME, 2020–2030 (KILOTON)
- TABLE 05.U.S. FOLLOW-ON MILK MARKET VALUE, 2020–2030 ($MILLION)
- TABLE 06.U.S. FOLLOW-ON MILK MARKET VOLUME , 2020–2030 (KILOTON)
- TABLE 07.U.S. SPECIALTY BABY MILK MARKET VALUE, 2020–2030 ($MILLION)
- TABLE 08.U.S. SPECIALTY BABY MILK MARKET VOLUME, 2020–2030 (KILOTON)
- TABLE 09.U.S. BABY INFANT FORMULA MARKET VALUE, BY POINT OF SALE, 2020–2030 ($MILLION)
- TABLE 10.U.S. GROWING-UP MILK MARKET VALUE, 2020–2030 ($MILLION)
- TABLE 11.U.S. GROWING-UP MILK MARKET VOLUME, 2020–2030 (KILOTON)
- TABLE 12.U.S. BABY INFANT FORMULA MARKET VALUE, BY INGREDIENT, 2020–2030 ($MILLION)
- TABLE 13.U.S. BABY INFANT FORMULA MARKET VALUE FOR CARBOHYDRATE, 2020–2030 ($MILLION)
- TABLE 14.U.S. BABY INFANT FORMULA MARKET VALUE FOR FAT, 2020–2030 ($MILLION)
- TABLE 15.U.S. BABY INFANT FORMULA MARKET VALUE FOR PROTEIN, 2020–2030 ($MILLION)
- TABLE 16.U.S. BABY INFANT FORMULA MARKET VALUE FOR MINERALS, 2020–2030 ($MILLION)
- TABLE 17.U.S. BABY INFANT FORMULA MARKET VALUE FOR VITAMINS, 2020–2030 ($MILLION)
- TABLE 18.U.S. BABY INFANT FORMULA MARKET VALUE FOR OTHERS, 2020–2030 ($MILLION)
- TABLE 19.U.S. BABY INFANT FORMULA MARKET VALUE, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
- TABLE 20.U.S. BABY INFANT FORMULA MARKET VALUE FOR HYPERMARKET, 2020–2030 ($MILLION)
- TABLE 21.U.S. BABY INFANT FORMULA MARKET VALUE FOR SUPERMARKET, 2020–2030 ($MILLION)
- TABLE 22.U.S. BABY INFANT FORMULA MARKET VALUE FOR PHARMACY/MEDICAL STORES, 2020–2030 ($MILLION)
- TABLE 23.U.S. BABY INFANT FORMULA MARKET VALUE FOR SPECIALTY STORES, 2020–2030 ($MILLION)
- TABLE 24.U.S. BABY INFANT FORMULA MARKET VALUE FOR HARD DISCOUNTER STORES, 2020–2030 ($MILLION)
- TABLE 25.U.S. BABY INFANT FORMULA MARKET VALUE FOR OTHERS, 2020–2030 ($MILLION)
- TABLE 26.U.S. BABY INFANT FORMULA MARKET VALUE, BY SOURCE, 2020–2030 ($MILLION)
- TABLE 27.U.S. BABY INFANT FORMULA MARKET VALUE FOR REGULAR, 2020–2030 ($MILLION)
- TABLE 28.U.S. BABY INFANT FORMULA MARKET VALUE FOR ORGANIC, 2020–2030 ($MILLION)
- TABLE 29.U.S. BABY INFANT FORMULA MARKET VALUE FOR MILK WITH HMO, 2020–2030 ($MILLION)
- TABLE 30.U.S. BABY INFANT FORMULA MARKET VALUE FOR GOAT MILK, 2020–2030 ($MILLION)
- TABLE 31.U.S. BABY INFANT FORMULA MARKET VALUE FOR PLANT-BASED FORMULA, 2020–2030 ($MILLION)
- TABLE 32.U.S. BABY INFANT FORMULA MARKET VALUE FOR OTHERS, 2020–2030 ($MILLION)
- TABLE 33.ABBOTT LABORATORIES: COMPANY SNAPSHOT
- TABLE 34.ABBOTT LABORATORIES: OPERATING SEGMENTS
- TABLE 35.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
- TABLE 36.ABBOTT LABORATORIES: DISTRIBUTION CHANNEL
- TABLE 37.ABBOTT LABORATORIES: R&D EXPENDITURE, 2019–2021 ($MILLION)
- TABLE 38.ABBOTT LABORATORIES: NET SALES, 2019–2021 ($MILLION)
- TABLE 39.ARLA FOODS AMBA: COMPANY SNAPSHOT
- TABLE 40.ARLA FOODS AMBA: OPERATING SEGMENTS
- TABLE 41.ARLA FOODS AMBA: PRODUCT PORTFOLIO
- TABLE 42.ARLA FOODS AMBA: DISTRIBUTION CHANNEL
- TABLE 43.ARLA FOODS: NET SALES, 2019–2021 ($MILLION)
- TABLE 44.AUSSIE BUBS, INC: COMPANY SNAPSHOT
- TABLE 45.AUSSIE BUBS, INC: PRODUCT PORTFOLIO
- TABLE 46.AUSSIE BUBS, INC: DISTRIBUTION CHANNEL
- TABLE 47.AUSSIE BUBS, INC: NET SALES, 2018–2020 ($MILLION)
- TABLE 48.KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 49.BOBBIE: COMPANY SNAPSHOT
- TABLE 50.BOBBIE: PRODUCT PORTFOLIO
- TABLE 51.BOBBIE: DISTRIBUTION CHANNEL
- TABLE 52.CAMPBELL SOUP COMPANY: COMPANY SNAPSHOT
- TABLE 53.CAMPBELL SOUP COMPANY: OPERATING SEGMENTS
- TABLE 54.CAMPBELL SOUP COMPANY: PRODUCT PORTFOLIO
- TABLE 55.CAMPBELL SOUP COMPANY: DISTRIBUTION CHANNEL
- TABLE 56.CAMPBELL SOUP COMPANY: R&D EXPENDITURE, 2019–2021 ($MILLION)
- TABLE 57.CAMPBELL SOUP COMPANY: NET SALES, 2019–2021 ($MILLION)
- TABLE 58.DANA DAIRY GROUP LTD.: COMPANY SNAPSHOT
- TABLE 59.DANA DAIRY GROUP LTD.: PRODUCT PORTFOLIO
- TABLE 60.DANA DAIRY GROUP LTD.: DISTRIBUTION CHANNEL
- TABLE 61.DANONE SA: COMPANY SNAPSHOT
- TABLE 62.DANONE SA: OPERATING SEGMENTS
- TABLE 63.DANONE SA: PRODUCT PORTFOLIO
- TABLE 64.DANONE SA: DISTRIBUTION CHANNEL
- TABLE 65.DANONE SA: NET SALES, 2018–2020 ($MILLION)
- TABLE 66.D-SIGNSTORE: COMPANY SNAPSHOT
- TABLE 67.D-SIGNSTORE: PRODUCT PORTFOLIO
- TABLE 68.D-SIGNSTORE: DISTRIBUTION CHANNEL
- TABLE 69.ELSE NUTRITION HOLDINGS INC.: COMPANY SNAPSHOT
- TABLE 70.ELSE NUTRITION HOLDINGS INC.: PRODUCT PORTFOLIO
- TABLE 71.ELSE NUTRITION HOLDINGS INC.: DISTRIBUTION CHANNEL
- TABLE 72.HIPP GMBH & CO. VERTRIEB KG: COMPANY SNAPSHOT
- TABLE 73.HIPP GMBH & CO. VERTRIEB KG: PRODUCT PORTFOLIO
- TABLE 74.HIPP GMBH & CO. VERTRIEB KG: DISTRIBUTION CHANNEL
- TABLE 75.HOLLE BABY FOOD AG: COMPANY SNAPSHOT
- TABLE 76.HOLLE BABY FOOD AG: PRODUCT PORTFOLIO
- TABLE 77.HOLLE BABY FOOD AG: DISTRIBUTION CHANNEL
- TABLE 78.KABRITA USA: COMPANY SNAPSHOT
- TABLE 79.KABRITA USA: PRODUCT PORTFOLIO
- TABLE 80.KABRITA USA: DISTRIBUTION CHANNEL
- TABLE 81.NATURE’S ONE, LLC: COMPANY SNAPSHOT
- TABLE 82.NATURE’S ONE, LLC: PRODUCT PORTFOLIO
- TABLE 83.NATURE’S ONE, LLC: DISTRIBUTION CHANNEL
- TABLE 84.NESTLE S.A: COMPANY SNAPSHOT
- TABLE 85.NESTLE S.A: OPERATING SEGMENTS
- TABLE 86.NESTLE S.A: PRODUCT PORTFOLIO
- TABLE 87.NESTLE S.A: DISTRIBUTION CHANNEL
- TABLE 88.NESTLE S.A: NET SALES, 2019–2021 ($MILLION)
- TABLE 89.RECKITT BENCKISER GROUP PLC.: COMPANY SNAPSHOT
- TABLE 90.RECKITT BENCKISER GROUP PLC: OPERATING SEGMENTS
- TABLE 91.RECKITT BENCKISER GROUP PLC: PRODUCT PORTFOLIO
- TABLE 92.RECKITT BENCKISER GROUP PLC: DISTRIBUTION CHANNEL
- TABLE 93.RECKITT BENCKISER GROUP PLC: R&D EXPENDITURE, 2018–2020 ($MILLION)
- TABLE 94.RECKITT BENCKISER GROUP PLC: NET SALES, 2018–2020 ($MILLION)
- TABLE 95.THE HAIN CELESTIAL GROUP, INC.: COMPANY SNAPSHOT
- TABLE 96.THE HAIN CELESTIAL GROUP, INC: PRODUCT PORTFOLIO
- TABLE 97.THE HAIN CELESTIAL GROUP, INC: DISTRIBUTION CHANNEL
- TABLE 98.THE HAIN CELESTIAL INC.: R&D EXPENDITURE, 2016–2018 ($MILLION)
- TABLE 99.THE HAIN CELESTIAL INC.: NET SALES, 2019–2021 ($MILLION)
- LIST OF FIGURES
- FIGURE 01.KEY MARKET SEGMENTS
- FIGURE 02.U.S. BABY INFANT FORMULA MARKET SNAPSHOT, 2020–2030
- FIGURE 03.TOP INVESTMENT POCKETS, 2020
- FIGURE 04.LOW BARGAINING POWER OF SUPPLIERS
- FIGURE 05.LOW BARGAINING POWER OF BUYERS
- FIGURE 06.LOW THREAT OF NEW ENTRANTS
- FIGURE 07.LOW THREAT OF SUBSTITUTES
- FIGURE 08.MODERATE INTENSITY OF COMPETITIVE RIVALRY
- FIGURE 09.MARKET DYNAMIC ANALYSIS
- FIGURE 10.IMPACT OF KEY REGULATION: U.S. BABY INFANT FORMULA MARKET
- FIGURE 11.U.S. BABY INFANT FORMULA MARKET SHARE, BY PRODUCT TYPE, 2020 (%)
- FIGURE 12.U.S. BABY INFANT FORMULA MARKET SHARE, BY INGRIDIENT, 2020 (%)
- FIGURE 13.U.S. BABY INFANT FORMULA MARKET SHARE, BY DISTRIBUTION CHANNEL, 2020 (%)
- FIGURE 14.U.S. BABY INFANT FORMULA MARKET SHARE, BY SOURCE, 2020 (%)
- FIGURE 15.TOP WINNING STRATEGIES, BY YEAR, 2019–2021*
- FIGURE 16.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2019–2021* (%)
- FIGURE 17.TOP WINNING STRATEGIES, BY COMPANY, 2019–2021*
- FIGURE 18.PRODUCT MAPPING OF TOP 10 KEY PLAYERS
- FIGURE 19.COMPETITIVE DASHBOARD OF TOP 10 KEY PLAYERS
- FIGURE 20.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
- FIGURE 21.ABBOTT LABORATORIES: R&D EXPENDITURE, 2019–2021 ($MILLION)
- FIGURE 22.ABBOTT LABORATORIES: NET SALES, 2019–2021 ($MILLION)
- FIGURE 23.ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2021 (%)
- FIGURE 24.ABBOTT LABORATORIES: REVENUE SHARE BY REGION, 2021 (%)
- FIGURE 25.ARLA FOODS AMBA: NET SALES, 2019–2021 ($MILLION)
- FIGURE 26.ARLA FOODS AMBA: REVENUE SHARE BY SEGMENT, 2021 (%)
- FIGURE 27.ARLA FOODS AMBA: REVENUE SHARE BY REGION, 2021 (%)
- FIGURE 28.AUSSIE BUBS, INC: NET SALES, 2018–2020 ($MILLION)
- FIGURE 29.AUSSIE BUBS, INC: REVENUE SHARE BY REGION, 2020 (%)
- FIGURE 30.CAMPBELL SOUP COMPANY: R&D EXPENDITURE, 2019–2021 ($MILLION)
- FIGURE 31.CAMPBELL SOUP COMPANY: NET SALES, 2019–2021 ($MILLION)
- FIGURE 32.CAMPBELL SOUP COMPANY: REVENUE SHARE BY SEGMENT, 2021 (%)
- FIGURE 33.CAMPBELL SOUP COMPANY: REVENUE SHARE BY REGION, 2021 (%)
- FIGURE 34.DANONE SA: NET SALES, 2018–2020 ($MILLION)
- FIGURE 35.DANONE SA: REVENUE SHARE BY REGION, 2020 (%)
- FIGURE 36.NESTLE S.A: NET SALES, 2019–2021 ($MILLION)
- FIGURE 37.NESTLE S.A: REVENUE SHARE BY REGION, 2021 (%)
- FIGURE 38.RECKITT BENCKISER GROUP PLC: R&D EXPENDITURE, 2018–2020 ($MILLION)
- FIGURE 39.RECKITT BENCKISER GROUP PLC: NET SALES, 2018–2020 ($MILLION)
- FIGURE 40.RECKITT BENCKISER GROUP PLC: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 41.RECKITT BENCKISER GROUP PLC: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 42.THE HAIN CELESTIAL INC.: R&D EXPENDITURE, 2019–2021 ($MILLION)
- FIGURE 43.THE HAIN CELESTIAL INC.: NET SALES, 2019–2021 ($MILLION)
- FIGURE 44.THE HAIN CELESTIAL INC.: REVENUE SHARE BY REGION, 2021 (%)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.